Janelle Perkins

1.6k total citations
67 papers, 1.2k citations indexed

About

Janelle Perkins is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Janelle Perkins has authored 67 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hematology, 25 papers in Public Health, Environmental and Occupational Health and 13 papers in Genetics. Recurrent topics in Janelle Perkins's work include Hematopoietic Stem Cell Transplantation (38 papers), Acute Lymphoblastic Leukemia research (23 papers) and Acute Myeloid Leukemia Research (11 papers). Janelle Perkins is often cited by papers focused on Hematopoietic Stem Cell Transplantation (38 papers), Acute Lymphoblastic Leukemia research (23 papers) and Acute Myeloid Leukemia Research (11 papers). Janelle Perkins collaborates with scholars based in United States, Lebanon and Italy. Janelle Perkins's co-authors include William E. Janssen, Claudio Anasetti, Teresa Field, Hugo F. Fernández, Mohamed A. Kharfan‐Dabaja, Lia Perez, Gerald J. Elfenbein, Karen K. Fields, Ernesto Ayala and Joseph Pidala and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Janelle Perkins

67 papers receiving 1.2k citations

Peers

Janelle Perkins

HEMAT

ONCOL

PHEOH

IMMUN

Thomas R. Klumpp United States

Esteban Abella United States

Hyun‐Sook Chi South Korea

Jeffrey Margolis United States

Antonio Torres Spain

Carol Reynolds United States

Radovan Sašo United Kingdom

Stephen J. Proctor United Kingdom

David Szwajcer Canada

Diane Coso France

Thomas R. Klumpp United States

Janelle Perkins

983 ×1.3

HEMAT

474 ×1.3

ONCOL

260 ×1.1

PHEOH

460 ×2.2

IMMUN

95 ×0.6

Citations per year, relative to Janelle Perkins Janelle Perkins (= 1×) peers Thomas R. Klumpp

Countries citing papers authored by Janelle Perkins

Since Specialization

Citations

This map shows the geographic impact of Janelle Perkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janelle Perkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janelle Perkins more than expected).

Fields of papers citing papers by Janelle Perkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janelle Perkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janelle Perkins. The network helps show where Janelle Perkins may publish in the future.

Co-authorship network of co-authors of Janelle Perkins

This figure shows the co-authorship network connecting the top 25 collaborators of Janelle Perkins. A scholar is included among the top collaborators of Janelle Perkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janelle Perkins. Janelle Perkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Perkins, Janelle, et al.. (2018). Enhancing Student Knowledge Through a Comprehensive Oncology Simulation. American Journal of Pharmaceutical Education. 82(3). 6245–6245. 20 indexed citations

Ayala, Ernesto, Janelle Perkins, Jongphil Kim, et al.. (2015). Myeloablative Intravenous Pharmacokinetically Targeted Busulfan Plus Fludarabine As Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients With Non-Hodgkin Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 15(6). 335–340. 6 indexed citations

Nishihori, Taiga, Janelle Perkins, Asmita Mishra, et al.. (2014). Pretransplantation 5-Azacitidine in High-Risk Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 20(6). 776–780. 17 indexed citations

Duong, Vu H., Jeffrey E. Lancet, Janelle Perkins, et al.. (2013). Outcome of azacitidine treatment in patients with therapy-related myeloid neoplasms with assessment of prognostic risk stratification models. Leukemia Research. 37(5). 510–515. 18 indexed citations

Kharfan-Dabaja, M A, Rahul Mhaskar, Joseph A. Pidala, et al.. (2012). Comparison of Mycophenolate Mofetil (MMF) Versus Methotrexate (MTX) for Prevention of Acute Graft-Versus-Host Disease: Results of a Meta-Analysis. Biology of Blood and Marrow Transplantation. 18(2). S358–S359. 1 indexed citations

Perkins, Janelle, Marcie Tomblyn, Teresa Field, et al.. (2012). Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma. Biology of Blood and Marrow Transplantation. 18(2). S297–S297. 1 indexed citations

Perkins, Janelle, Ryan Bookout, Gary C. Yee, et al.. (2012). Retrospective comparison of filgrastim plus plerixafor to other regimens for remobilization after primary mobilization failure: Clinical and economic outcomes. American Journal of Hematology. 87(7). 673–677. 7 indexed citations

Perkins, Janelle, Steven C. Goldstein, Jana L. Dawson, et al.. (2011). Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with Autologous Stem Cell Transplant in Refractory Cancer: Pharmacokinetic and Pharmacodynamic Correlates. Clinical Cancer Research. 17(24). 7743–7753. 3 indexed citations

Pidala, Joseph, Marcie Tomblyn, Teresa Field, et al.. (2011). Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids. Haematologica. 96(9). 1351–1356. 15 indexed citations

10.

Santarone, Stella, Joseph Pidala, Marta Di Nicola, et al.. (2011). Fludarabine and Pharmacokinetic-Targeted Busulfan before Allografting for Adults with Acute Lymphoid Leukemia. Biology of Blood and Marrow Transplantation. 17(10). 1505–1511. 23 indexed citations

11.

Perkins, Janelle, Jongphil Kim, Claudio Anasetti, et al.. (2011). Maximally Tolerated Busulfan Systemic Exposure in Combination with Fludarabine as Conditioning before Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 18(7). 1099–1107. 44 indexed citations

12.

Pidala, Joseph, Jongphil Kim, Claudio Anasetti, et al.. (2010). Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia. Journal of Hematology & Oncology. 3(1). 36–36. 41 indexed citations

13.

Kharfan‐Dabaja, Mohamed A., Julio C. Chávez, Daohai Yu, et al.. (2010). Severe Hypoalbuminemia at Day 90 Predicts Worse Nonrelapse Mortality and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 17(3). 384–393. 23 indexed citations

14.

Field, Teresa, Janelle Perkins, Yifan Huang, et al.. (2009). 5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 45(2). 255–260. 103 indexed citations

15.

Brinkman, Ryan R., et al.. (2007). High-Content Flow Cytometry and Temporal Data Analysis for Defining a Cellular Signature of Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 13(6). 691–700. 43 indexed citations

16.

Anasetti, Claudio, Janelle Perkins, Michael L. Nieder, & Teresa Field. (2006). Are matched unrelated donor transplants justified for AML in CR1?. Best Practice & Research Clinical Haematology. 19(2). 321–328. 8 indexed citations

17.

Ballester, Oscar, Todd W. Mattox, John W. Hiemenz, et al.. (1997). Nephrotoxicity of High-Dose Ifosfamide/Carboplatin/Etoposide in Adults Undergoing Autologous Stem Cell Transplantation. The American Journal of the Medical Sciences. 314(5). 292–298. 1 indexed citations

18.

Fields, Karen K., Gerald J. Elfenbein, Janelle Perkins, & Lynn C. Moscinski. (1995). High Dose versus Standard Dose Chemotherapy for the Treatment of Breast Cancer. Annals of the New York Academy of Sciences. 770(1). 288–304. 11 indexed citations

19.

Elfenbein, Gerald J., William E. Janssen, & Janelle Perkins. (1995). Relative Contributions of Marrow Microenvironment, Growth Factors, and Stem Cells to Hematopoiesis in Vivo in Man. Annals of the New York Academy of Sciences. 770(1). 315–338. 6 indexed citations

20.

Fields, Karen K., Gerald J. Elfenbein, Paul Zorsky, et al.. (1992). Ifosfamide, carboplatin, and etoposide in combination for induction and high‐dose chemotherapy: focus on breast cancer and lymphoma. Hematological Oncology. 10(1). 61–74. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact